DexCom Long Term Debt 2010-2025 | DXCM
DexCom long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- DexCom long term debt for the quarter ending June 30, 2025 was $1.239B, a 49.18% decline year-over-year.
- DexCom long term debt for 2024 was $1.237B, a 49.18% decline from 2023.
- DexCom long term debt for 2023 was $2.434B, a 103.24% increase from 2022.
- DexCom long term debt for 2022 was $1.198B, a 39.57% decline from 2021.
| DexCom Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $1,237 |
| 2023 | $2,434 |
| 2022 | $1,198 |
| 2021 | $1,982 |
| 2020 | $1,667 |
| 2019 | $1,060 |
| 2018 | $1,010 |
| 2017 | $328 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $2 |
| 2013 | $5 |
| 2012 | $7 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $46 |
| DexCom Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-06-30 | $1,239 |
| 2025-03-31 | $1,238 |
| 2024-12-31 | $1,237 |
| 2024-09-30 | $2,440 |
| 2024-06-30 | $2,438 |
| 2024-03-31 | $2,436 |
| 2023-12-31 | $2,434 |
| 2023-09-30 | $2,432 |
| 2023-06-30 | $2,431 |
| 2023-03-31 | $1,199 |
| 2022-12-31 | $1,198 |
| 2022-09-30 | $1,969 |
| 2022-06-30 | $1,967 |
| 2022-03-31 | $1,966 |
| 2021-12-31 | $1,982 |
| 2021-09-30 | $1,704 |
| 2021-06-30 | $1,711 |
| 2021-03-31 | $1,689 |
| 2020-12-31 | $1,667 |
| 2020-09-30 | $1,646 |
| 2020-06-30 | $1,659 |
| 2020-03-31 | $1,072 |
| 2019-12-31 | $1,060 |
| 2019-09-30 | $1,047 |
| 2019-06-30 | $1,035 |
| 2019-03-31 | $1,022 |
| 2018-12-31 | $1,010 |
| 2018-09-30 | $339 |
| 2018-06-30 | $335 |
| 2018-03-31 | $331 |
| 2017-12-31 | $328 |
| 2017-09-30 | $324 |
| 2017-06-30 | $321 |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2015-06-30 | $1 |
| 2015-03-31 | $2 |
| 2014-12-31 | $2 |
| 2014-09-30 | $3 |
| 2014-06-30 | $4 |
| 2014-03-31 | $4 |
| 2013-12-31 | $5 |
| 2013-09-30 | $5 |
| 2013-06-30 | $6 |
| 2013-03-31 | $6 |
| 2012-12-31 | $7 |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | $1 |
| 2010-06-30 | $3 |
| 2010-03-31 | $5 |
| 2009-12-31 | $46 |
| 2009-09-30 | $45 |
| 2009-06-30 | $2 |
| 2009-03-31 | $43 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $31.694B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.101B | 22.27 |
| Intuitive Surgical (ISRG) | United States | $172.528B | 71.51 |
| IDEXX Laboratories (IDXX) | United States | $51.032B | 53.11 |
| Edwards Lifesciences (EW) | United States | $45.970B | 30.47 |
| Alcon (ALC) | Switzerland | $43.470B | 29.38 |
| IQVIA Holdings (IQV) | United States | $32.732B | 18.50 |
| Mettler-Toledo (MTD) | United States | $27.012B | 32.06 |
| STERIS (STE) | Ireland | $24.087B | 25.64 |
| Waters (WAT) | United States | $17.226B | 23.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.782B | 0.00 |
| Hologic (HOLX) | United States | $14.962B | 16.21 |
| Penumbra (PEN) | United States | $9.958B | 72.75 |
| Sysmex ADR (SSMXY) | Japan | $8.391B | 26.66 |
| Masimo (MASI) | United States | $8.362B | 28.14 |
| Globus Medical (GMED) | United States | $8.137B | 18.77 |
| Teleflex (TFX) | United States | $5.297B | 8.55 |
| Glaukos (GKOS) | United States | $5.134B | 0.00 |
| TransMedics (TMDX) | United States | $4.283B | 65.10 |
| Integer Holdings (ITGR) | United States | $3.698B | 18.45 |
| LivaNova (LIVN) | United Kingdom | $2.909B | 16.65 |
| Veracyte (VCYT) | United States | $2.366B | 32.69 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.265B | 0.00 |
| Artivion (AORT) | United States | $2.022B | 102.02 |
| Nihon Kohden (NHNKY) | Japan | $1.999B | 23.86 |
| Elekta AB (EKTAY) | Sweden | $1.847B | 17.28 |
| OPKO Health (OPK) | United States | $1.111B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.095B | 6.27 |
| Pulse Biosciences (PLSE) | United States | $1.055B | 0.00 |
| IRadimed (IRMD) | United States | $0.892B | 43.28 |
| Beta Bionics (BBNX) | United States | $0.750B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.732B | 0.00 |
| AxoGen (AXGN) | United States | $0.713B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.522B | 9.22 |
| Semler Scientific (SMLR) | United States | $0.500B | 4.01 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.445B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.376B | 9.57 |
| Delcath Systems (DCTH) | United States | $0.373B | 88.75 |
| AngioDynamics (ANGO) | United States | $0.357B | 0.00 |
| RxSight (RXST) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.35 |
| NeuroPace (NPCE) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.232B | 0.00 |
| 908 Devices (MASS) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.204B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.180B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.172B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.116B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.096B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.076B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 20.89 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |